Ordering a CRISPR Lateral Flow Reporter: A Specification Checklist

Before ordering a custom reporter for a CRISPR lateral flow assay, turn the design into an explicit specification. A label name in an email is not enough to define the molecule, its quantity or the material that will reach your experiment.

This checklist is for research procurement and design review. It is not a validated reporter sequence or an assay protocol.

1. Name the readout component first

Record the exact strip model and current instructions. The Due Bio Cas12/13 strip page describes reporter labels involving biotin and FITC or 6-FAM. That product description does not establish compatibility with every reporter sequence, enzyme preparation or reaction mixture. Confirm the intended design with the strip supplier before placing the oligo order.

2. Write the molecule without ambiguous shorthand

Specify the sequence orientation, nucleic acid chemistry and every modification at its intended position. Ask the synthesis provider to expand catalogue-specific modification codes into their full chemical descriptions. Confirm whether linkers or other attachments are included. Keep the supplier-approved representation alongside your internal design identifier so another team member can review the same molecule.

3. Separate total yield from amount per tube

Order field What to make explicit
Molecule identity Sequence, chemistry, orientation and modification positions
Quantity Total requested amount, number of tubes and amount of each component per tube
Presentation Individual oligos or a combined mixture; dry material or solution
Processing Agreed purification method, additional processing and requested quality documents
Handling Supplier-specified storage, shipping and reconstitution instructions

If several oligos share one tube, list each component and its amount separately. Do not assume the synthesis minimum equals the final amount per tube. If the quote uses optical-density units, ask the provider for the corresponding molar quantity for each specific oligo and its stated calculation basis.

4. Define what a dry tube contains

State whether the requested dry material contains only oligos or includes buffer components, stabilizers, enzymes or other reagents. Ask the processing provider to confirm the formulation and reconstitution instructions. Do not infer the delivered amount or identity from the visible size of the dry material.

5. Agree on documents and change control

Specify which identity and purity documents are required and confirm availability before ordering. Retain the accepted quotation, approved sequence representation, batch identifiers and received documentation. Ask the supplier to obtain approval before changing a modification, purification method, formulation or packaging specification.

Evaluate the received reporter with the intended strip and reaction conditions, including appropriate controls. A synthesis quality report is useful procurement evidence, but it does not establish the performance of the complete detection workflow.

Discuss your reporter and strip together

Send the Cas system, reporter labels, proposed strip model, evaluation quantity and expected bulk demand through the Due Bio contact page. Share confidential sequence details only under appropriate information-sharing arrangements. Use the pilot acceptance guide to plan downstream evaluation, and consult the literature collection for application examples whose methods should be reviewed individually.

TL
Global Agent · Duebio (TiosBio) · 20+ Years in IVD
IVD industry veteran specializing in CRISPR Cas12/Cas13 detection, RAA isothermal amplification, lateral flow assays, microfluidic PCR, TRF immunoassays, and OEM/ODM IVD development for global distributors. Duebio is the international trade brand of TiosBio, a Chinese IVD manufacturer with 20+ years of experience.

Leave a Comment